Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Kestra Medical Technologies (NASDAQ: KMTS) will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 2:15 p.m. PT.

Investors and interested parties can access a live webcast and replay via the company's investor relations website.

Key Figures

Conference edition 44th Annual J.P. Morgan Healthcare Conference

Presentation date January 13 Conference presentation schedule

Presentation time 2:15 p.m. Pacific Time Scheduled conference slot

Market Reality Check

$24.39 Last Close

Volume Volume 188,081 is 0.41x the 20-day average of 453,867, indicating lighter trading ahead of the conference. low

Technical Shares at $26.43 are trading above the 200-day MA of $21.90, with the stock also below its 52-week high of $29.9999 and above its 52-week low of $13.25.

Peers on Argus

Sector peers show mixed moves today, with EMBC and PLSE down while BLFS, STAA, and ATRC are up, suggesting KMTS trading dynamics are more company-specific than driven by a broad medical instruments move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 11	Earnings results	Positive	+1.6%	Reported strong Q2 FY2026 growth and raised full-year revenue guidance.
Dec 03	Earnings date notice	Neutral	+12.2%	Announced timing and access details for upcoming Q2 FY2026 results call.
Dec 02	Equity offering priced	Negative	-6.8%	Priced upsized public offering of 6,000,000 common shares at $23.00.
Dec 01	Equity offering launch	Negative	-8.5%	Proposed underwritten public offering of 5,500,000 shares with overallotment.
Dec 01	Preliminary earnings	Positive	-8.5%	Preliminary Q2 results showed ~52% revenue growth and ~50% gross margin.

Pattern Detected

Recent news reactions show mostly aligned moves: positive earnings and financing announcements generally saw price changes consistent with their tone, except for a divergence on preliminary earnings where strong growth coincided with a negative move.

Recent Company History

Over the last month, KMTS has reported strong growth, with Q2 FY2026 revenue of $22.6M, up 53% year over year, and gross margin improving to 50.6%. The company completed an upsized public offering of 6,000,000 shares at $23.00, following a proposed 5,500,000-share offering on Dec 1, 2025. Preliminary Q2 results and the final earnings release both highlighted robust momentum, and today’s conference appearance fits into an active investor communication pattern.

Market Pulse Summary

This announcement highlights KMTS’s participation in a major healthcare investor conference, with a scheduled presentation on January 13 at 2:15 p.m. Pacific Time. Against a backdrop of recent strong Q2 FY2026 results and capital-raising activity, the conference slot offers another platform for management to discuss growth, margin trends, and strategy. Investors may watch for updates that build on prior guidance and clarify how recent proceeds support commercialization and development priorities.

Key Terms

wearable medical device medical

"Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled"

A wearable medical device is an electronic tool designed to be worn on the body—like a patch, band, or clip—that continuously monitors, measures or supports health functions such as heart rate, glucose, movement or breathing. Investors care because these devices can create steady data streams, recurring revenue from services or subscriptions, and potential cost savings for healthcare systems; their value depends on regulation, reimbursement and user adoption, much like a smart thermostat for your body.

webcast technical

"Interested parties may access the live webcast and replay of the presentation by visiting"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 2:15 p.m. Pacific Time.

Interested parties may access the live webcast and replay of the presentation by visiting the Kestra Medical Technologies investor relations website.

About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact
Neil Bhalodkar
neil.bhalodkar@kestramedical.com 

FAQ

When will Kestra Medical Technologies (KMTS) present at the J.P. Morgan Healthcare Conference?

Kestra will present on Tuesday, January 13, 2026 at 2:15 p.m. Pacific Time.

How can investors watch the KMTS presentation at the J.P. Morgan Healthcare Conference?

Investors can watch the live webcast and replay on Kestra Medical Technologies' investor relations website.

What is the event where KMTS will present on January 13, 2026?

KMTS will present at the 44th Annual J.P. Morgan Healthcare Conference.

Will there be a replay available for the KMTS presentation at JPM 2026?

Yes, a replay will be available via the company's investor relations website after the live webcast.

What is Kestra Medical Technologies' Nasdaq ticker for conference reference?

The company's Nasdaq ticker is KMTS.

Where can I find the KMTS webcast link for the J.P. Morgan Healthcare Conference?

The webcast link and replay will be posted on Kestra Medical Technologies' investor relations website.